2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease

Alzheimers Dement. 2014 Oct;10(5 Suppl):S430-52. doi: 10.1016/j.jalz.2014.08.103.

Abstract

With increasing numbers of people with Alzheimer's and other dementias across the globe, many countries have developed national plans to deal with the resulting challenges. In the United States, the National Alzheimer's Project Act, signed into law in 2011, required the creation of such a plan with annual updates thereafter. Pursuant to this, the US Department of Health and Human Services (HHS) released the National Plan to Address Alzheimer's Disease in 2012, including an ambitious research goal of preventing and effectively treating Alzheimer's disease by 2025. To guide investments, activities, and the measurement of progress toward achieving this 2025 goal, in its first annual plan update (2013) HHS also incorporated into the plan a set of short, medium and long-term milestones. HHS further committed to updating these milestones on an ongoing basis to account for progress and setbacks, and emerging opportunities and obstacles. To assist HHS as it updates these milestones, the Alzheimer's Association convened a National Plan Milestone Workgroup consisting of scientific experts representing all areas of Alzheimer's and dementia research. The workgroup evaluated each milestone and made recommendations to ensure that they collectively constitute an adequate work plan for reaching the goal of preventing and effectively treating Alzheimer's by 2025. This report presents these Workgroup recommendations.

Keywords: Milestones; National Plan to Address Alzheimer's Disease; Policy.

MeSH terms

  • Alzheimer Disease / epidemiology
  • Alzheimer Disease / physiopathology
  • Alzheimer Disease / prevention & control*
  • Alzheimer Disease / therapy*
  • Animals
  • Biological Ontologies
  • Biomarkers / metabolism
  • Drug Discovery
  • Health Policy*
  • Humans
  • Patient Selection
  • Public-Private Sector Partnerships
  • Translational Research, Biomedical / methods
  • United States
  • United States Dept. of Health and Human Services
  • Voluntary Health Agencies

Substances

  • Biomarkers